Waters Corporation (NYSE:WAT) introduced ACQUITY™ PREMIER Columns, a new family of premium sub-2-micron columns featuring MaxPeak™ High Performance Surface (HPS) technology.

Antlia Bioscience, Inc., and XL-protein GmbH are pleased to announce a strategic slliance using XL-protein's proprietary PASylation® technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure.

A test for COVID-19 which works in just 25 minutes, with high accuracy and requiring only routine laboratory equipment, is currently in the final stages of clinical validation by British biotech firm MicrosensDx.

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today the results of a new study published in the International Journal of Laboratory Hematology demonstrating that the company’s HemoScreen™ point-of-care hematology analyzer is suitable for the evaluation and management of patients receiving chemotherapy treatment for hematological cancers.

BioChromato Inc. has published a technical poster that studies how its unique vacuum-assisted vortex concentration (VVC) technology offers significant benefits in achieving rapid concentration of samples dissolved in high boiling point solvents.

BioChromato Inc. reports that the pharmacokinetics department at a leading Japanese pharmaceutical company has found that RAPID Slit Seals offer significant benefits compared to conventional silicone mats for maintaining the integrity of microplate samples.

BioChromato Inc. reports how the Department of Bioimaging Information Analysis at Gunma University (Japan) is benefiting from the ability of its Smart Evaporator C1 to safely and efficiently concentrate low volume samples.

Formedix, announces expansion of its development and test teams. By expanding the workforce, Formedix can stay abreast of technological breakthroughs and meet greater client demands for the enhancement and advancement of its platform.

BioGX, a molecular diagnostics solutions company, announced FDA Emergency Use Authorization (EUA) submission of an extraction-free, direct sample addition RT-PCR test for detection of SARS-CoV-2 viral RNA in patients suspected of COVID-19.

Dotmatics Ltd, today announced it has expanded its product portfolio to include Blueprint, a self-service, scientific visualization and analytics application for small molecule discovery.